candesartan has been researched along with Pressure Ulcer in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Pressure Ulcer: An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study examines whether the AT1R blocker candesartan (1) has a beneficial effect on diabetes-induced alteration of pressure-induced vasodilation (PIV, a cutaneous physiological neurovascular mechanism which could delay the occurrence of tissue ischemia), and (2) could be protective against skin pressure ulcer formation." | 7.81 | Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice. ( Achard, JM; Bessaguet, F; Danigo, A; Demiot, C; Javellaud, J; Nasser, M; Oudart, N, 2015) |
| " The present study examines whether the AT1R blocker candesartan (1) has a beneficial effect on diabetes-induced alteration of pressure-induced vasodilation (PIV, a cutaneous physiological neurovascular mechanism which could delay the occurrence of tissue ischemia), and (2) could be protective against skin pressure ulcer formation." | 3.81 | Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice. ( Achard, JM; Bessaguet, F; Danigo, A; Demiot, C; Javellaud, J; Nasser, M; Oudart, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danigo, A | 1 |
| Nasser, M | 1 |
| Bessaguet, F | 1 |
| Javellaud, J | 1 |
| Oudart, N | 1 |
| Achard, JM | 1 |
| Demiot, C | 1 |
1 other study available for candesartan and Pressure Ulcer
| Article | Year |
|---|---|
Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Diabetes Melli | 2015 |